Please try another search
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company’s lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Name | Age | Since | Title |
---|---|---|---|
John F. Carpenter | - | - | Member of Scientific Advisory Board |
James P. Sherblom | 68 | 2021 | Independent Director |
John Yee | 60 | 2022 | Scientific Advisory Board |
Sirshendu Roopom Banerjee | 47 | 2021 | Independent Director |
Andrew J.S. Jones | - | - | Member of Scientific Advisory Board |
John M. Sorvillo | 69 | - | Chairman of Scientific Advisory Board |
Alan C. Herman | 76 | - | Member of Scientific Advisory Board |
David Soane | - | - | Co-Founder & Member of Scientific Advisory Board |
V. Bryan Lawlis | 72 | - | Member of Scientific Advisory Board |
Barbara K. Finck | 77 | 2022 | Scientific Advisory Board |
Edward Sullivan | 61 | 2021 | Independent Director |
Dorothy J. Clarke | 58 | 2023 | Director |
Kirsten Flowers | 49 | 2021 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review